tenapanor

FDA grants appeal for Ardelyx chronic kidney disease drug after July 2021 rejection
Endpoints
Fri, 12/30/22 - 10:40 am
Ardelyx
chronic kidney disease
FDA
tenapanor
In surprise turn, FDA adcomm votes in favor of Ardelyx CKD drug despite agency questions
Endpoints
Wed, 11/16/22 - 11:30 pm
Ardelyx
FDA
chronic kidney disease
tenapanor
ASN to Spotlight Debate around Ardelyx's Embattled CKD Drug
BioSpace
Tue, 11/1/22 - 11:56 am
Ardelyx
FDA
tenapanor
chronic kidney disease
Ardelyx amends license deal with Kyowa Kirin for tenapanor
Pharmaceutical Business Review
Tue, 04/12/22 - 10:40 am
Ardelyx
Kyowa Kirin
tenapanor
FDA denies Ardelyx’s appeal against kidney drug rejection, hammering another nail in tenapanor’s coffin
Fierce Biotech
Thu, 02/10/22 - 10:30 am
Ardelyx
FDA
complete response letter
tenapanor
chronic kidney disease
Ardelyx Prepares for Battle with FDA Over Rejected CKD Drug
BioSpace
Sun, 11/7/21 - 10:47 pm
Ardelyx
chronic kidney disease
tenapanor
FDA
Ardelyx chops a third of its staff after stock-crushing failure in chronic kidney disease
Endpoints
Wed, 08/4/21 - 11:00 am
Ardelyx
chronic kidney disease
layoffs
tenapanor
FDA turns down Ardelyx’s chronic kidney disease drug and asks for another trial
MedCity News
Thu, 07/29/21 - 11:06 pm
Ardelyx
tenapanor
FDA
chronic kidney disease
Ardelyx’s ambition to revolutionize kidney treatment
Pharmaforum
Thu, 12/17/20 - 11:07 am
Ardelyx
tenapanor
hyperphosphatemia
Ardelyx's kidney disease drug hits goal in phase 3, teeing it up for FDA filing
Fierce Biotech
Tue, 12/3/19 - 10:29 am
Ardelyx
chronic kidney disease
tenapanor
clinical trials
Ardelyx bags its first FDA OK for IBS, setting up a showdown with Allergan, Ironwood
Endpoints
Sun, 09/15/19 - 09:45 pm
Ardelyx
Ibsrela
tenapanor
IBS-C
FDA
Ardelyx eyes first drug approval after decade-long journey
Bizjournals
Thu, 09/12/19 - 10:20 am
Ardelyx
tenapanor
IBS-C
FDA
Mark Your Calendar For These September PDUFA Dates
Yahoo/Benzinga
Wed, 08/28/19 - 12:53 pm
FDA
Roche
Celgene
Tecentriq
Xeris Pharmaceuticals
Gvoke
Ardelyx
tenapanor
Merck
Pifeltro
Delstrigo
Novo Nordisk
semaglutide
JNJ
Genmab
daratumumab
Invokana
Ardelyx Announces $50 Million Stock Offering
CP Wire
Wed, 05/23/18 - 09:44 am
Ardelyx
tenapanor
stock offering
AstraZeneca partner Ardelyx plunges after citing safety issue for lead drug
Fierce Biotech
Mon, 02/2/15 - 03:21 pm
AstraZeneca
Ardelyx
tenapanor
IBS
Ardelyx irritable bowel syndrome drug succeeds in mid-stage trial
Reuters
Wed, 10/1/14 - 08:19 am
Ardelyx
IBS
irritable bowel syndrome
tenapanor
AstraZeneca Pharma India